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Autoantibodies in patients with autoimmune bullous
skin diseases, such as pemphigus or bullous pemphigoid
are of diagnostic value and might play a part in the
pathogenic scenario. In this study we present ¢ve pa-
tients with erythematous plaques, subepidermal blister
formation of the skin, and the presence of circulating
autoantibodies directed against a so far unrecognized
190 kDa antigen in human keratinocytes. Amino acid
sequence analysis identi¢ed the protein as IQGAP1, a
recently described human Ras GTPase-activating-like
protein suspected to act as an e¡ector molecule for
Cdc42 and Rac1, members of the Rho small GTPase fa-
mily and to play a key part in regulating E-cadherin-
mediated cell adhesion. The protein is selectively
recognized by a monoclonal anti-IQGAP1 antibody on
western blots and immunoprecipitates from keratino-
cyte extracts. Indirect immuno£uorescence locates IQ-
GAP1 within individual keratinocytes in a cytoplasmic
pattern and along the cell periphery at adhesive sites.
Our results demonstrate IQGAP1, a newly described
multifunctional protein, to be constitutively expressed
in human keratinocytes where it may contribute to the
integrity of the epidermal layer. Furthermore, we found
autoantibodies reacting with IQGAP1 in patients with
bullous skin eruptions most apparently belonging to
the spectrum of bullous pemphigoid. Key words: autoim-
munity/cellular structure/epidermal proteins/subepidermal blis-
tering. J Invest Dermatol 120:365 ^371, 2003
A
utoimmune bullous skin diseases, such as disorders
of the pemphigus group or bullous pemphigoid
(BP) are de¢ned by typical clinical presentation, dis-
tinct histologic and immunomorphologic changes
of lesional or perilesional skin, and by the presence
of serum autoantibodies directed against speci¢c epidermal anti-
gens (Amagai et al, 1991; Stanley, 1993; Nousari and Anhalt, 1999;
Anhalt and Diaz, 2001). Several studies have revealed important
components of the cellular and humoral autoreactive pathologic
events in these autoimmune bullous skin diseases, including the
antigens involved (Anhalt et al, 1990; Koch et al, 1997; Amagai et al,
1998, 2000; Lin et al, 2000), the associated major histocompatibil-
ity complex class II genes (Sinha et al, 1988), and the direct e¡ect
of antibody^antigen binding, e.g., in pemphigus vulgaris or para-
neoplastic pemphigus by passive transfer of serum autoantibodies
into newborn mice (Anhalt et al, 1982, 1990). Patients with pem-
phigus vulgaris or pemphigus foliaceus develop lesions of the
skin and mucous membranes exhibiting loss of cell^cell adhesion
among keratinocytes resulting in intraepidermal blister formation
(Amagai et al, 1991; Stanley, 1993; Nousari and Anhalt, 1999;
Anhalt and Diaz, 2001). These disorders are characterized by the
presence of in vivo bound and circulating autoantibodies directed
against desmoglein 1 and/or desmoglein 3, members of the cad-
herin family mediating cell^cell adhesion (Amagai et al, 1991;
Buxton et al, 1993; Stanley, 1993; Anhalt and Diaz, 2001). In the
more recent past, paraneoplastic pemphigus has been described
in patients with underlying neoplasms developing severe erosions
of the mucous membranes, erythema multiforme-like or liche-
noid skin eruptions, and associated lethal pulmonary involve-
ment (Anhalt et al, 1990; Nousari and Anhalt, 1999). The
heterogeneous clinical features of paraneoplastic pemphigus are
coexistent with the presence of distinctive serum autoantibodies
directed against a group of antigens, including desmoglein 1 and
3 and proteins of the plakin group as there are desmoplakin I and
II, BP antigen (BPAG) 1, periplakin, envoplakin, and plectin
(Anhalt et al, 1990; Amagai et al, 1998; Kiyokawa et al, 1998; Proby
et al, 1999). Autoantibodies directed against desmoplakin I and II
have further been shown in a severe subset of erythema multi-
forme, a syndrome of in£ammatory skin eruptions (Hu¡ et al,
1983) with erythematous iris-like plaques, blistering, and involve-
ment of the mucous membranes but without underlying
neoplasms; this indicates that in addition to T cell-mediated
pathophysiologic events operative in erythema multiforme, hu-
moral autoimmunity against the desmoplakins may play a crucial
part in this disease subset (Foedinger et al, 1995, 1998). Autoanti-
bodies targeting molecules of the dermoepidermal basement
membrane zone are found in BP associated with subepidermal
bulla formation (Mutasim et al, 1989; Stanley, 1993; Nousari and
Anhalt, 1999). BPAG 1, known as a member of the plakin family
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of proteins (Muller et al, 1989; Ruhrberg andWatt, 1997), is found
at the cytoplasmic plaque of hemidesmosomes, whereas BPAG 2
also designated type XVII collagen is a transmembrane protein
with collagenous repeats in its extracellular domain (Areida et al,
2001).
In this study, we show expression of the human RasGAP(GT-
Pase-activating protein)-like protein IQGAP1 (Weissbach et al,
1994) in human keratinocytes. IQGAP1 is a recently described
RasGAP-related protein that acts as an e¡ector molecule for
Cdc42 and Rac1, members of the Rho small GTPase family, to
mediate cellular processes involving calmodulin (Weissbach et al,
1994). It is thought to play a key part in regulating E-cadherin
mediated cell^cell adhesion and cytoskeletal organization (Kuro-
da et al, 1998). Additionally, we report for the ¢rst time, IQGAP1
as antigenic target for circulating autoantibodies in patients with
distinct bullous skin eruptions.
MATERIALS AND METHODS
Patients Two hundred and ¢ve sera of patients with pemphigus vulgaris
(n¼ 30), pemphigus foliaceus (n¼ 5), erythema multiforme (n¼ 80),
and BP (n¼ 90) were investigated for the presence of circulating
autoantibodies directed against epidermal antigens. Five patients with
anti-190 kDa autoantibodies (age 31^88, two male and three female)
exhibited disseminated plaques and bullous skin eruptions localized
predominantly on acral sites. The skin lesions varied in number and size,
with intact small blisters or larger bullae, urticarial or targetoid plaques
with and without erosions. Two of them (patients 1 and 2) showed mild
involvement of the oral mucous membranes. Clinical diagnoses were
bullous erythema multiforme (patient 1), erythema multiforme-like
eruption (patients 2 and 3), and BP (patients 4 and 5). Skin lesions of all
patients cleared under systemic treatment with steroids, and, recurred
infrequently upon cessation of therapy. Patient 1 presented a 10 y history
of recurrent erythema multiforme obviously associated with herpes
simplex infection and had, in addition, a Helicobacter pylori-positive
gastritis. Patient 2 was su¡ering from colitis ulcerosa and patient 4 had a
history of colon carcinoma treated surgically 7 y before the outbreak of
the bullous disease. Screening of all patients by laboratory parameters, X-
ray and computed tomography was negative for underlying neoplasia at
the time of observation.
Tissue, sera, and antibodies Biopsy specimens of skin lesions were
processed for routine histology and for direct immuno£uorescence as
described (Foedinger et al, 1998). Samples for immuno£uorescence are
placed in RPMI 1640 media (Gibco, Paisley, Scotland, U.K.) for transport.
Sections of monkey esophagus were purchased from INOVA (San Diego,
CA). Normal human skin was obtained from healthy volunteers and
processed for indirect immuno£uorescence and split skin diagnosis
according to methods routinely used in our laboratory. Shortly, normal
human skin was exposed to 1 mM NaCl for 48^72 h to form split skin
and subsequently snap frozen in liquid nitrogen. Cryosections (4 mm)
were prepared from split skin samples as well as snap frozen normal
human skin. Serum samples from the ¢ve patients described above were
used to perform experiments to assess the speci¢city of the 190 kDa
antigen. For control experiments, sera of patients with paraneoplastic
pemphigus (n¼ 2), BP (n¼ 6), and from healthy volunteers (n¼10) were
used.
Mouse monoclonal anti-IQGAP1 antibody (clone 24) and polyclonal
rabbit anti-IQGAP1 antibody (raised against a recombinant protein
corresponding to amino acids 314^422 of IQGAP1 from human origin)
were purchased from Transduction Laboratories (Lexington, KY) and
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), respectively. Mouse
monoclonal antibody to desmoglein (clone dg 3.10) was from Progen
(Heidelberg, Germany). For control immunoprecipitation we used an
isotype matched murine antibody (Pharmingen, San Diego, CA). As
second step reagents for immuno£uorescence we applied £uorescein
isothiocyanate conjugated goat anti-human C3 (INCSTAR Corporation,
Stillwater, MN), a⁄nity-puri¢ed FITC-conjugated goat F(ab0)2 anti-
human IgG (Jaxell, San Diego, CA),TRITC-conjugated goat F(ab0)2 anti-
mouse IgG (Jaxell), and for immunoblotting experiments, alkaline
phosphatase-conjugated goat anti-human, goat anti-mouse IgG, and goat
anti-rabbit IgG (Promega Corp., Madison,WI).
Immuno£uorescence experiments Cryosections of normal human
and split skin samples as well as monkey esophagus were incubated with
serum samples of interest, diluted 1 : 40 in phosphate-bu¡ered saline
(PBS)/0.1% bovine serum albumin (BSA) (Sigma, St Louis, MO). For
detection of bound antibodies FITC-conjugated goat F(ab0)2 anti-human
IgG was used diluted 1 : 100 in PBS/0.1% BSA. For direct immuno-
£uorescence, 4 mm cryosections of skin samples were prepared,
preincubated with PBS/1% BSA, and exposed to FITC-conjugated goat
F(ab0)2 anti-human IgG (Jaxell) or FITC-conjugated goat anti-human C3
antibody (INCstar Corporation). For indirect immuno£uorescence on
cultured keratinocytes, normal human keratinocytes obtained from
surgically removed skin were grown to con£uence in chamber slides
(Falcon, Becton Dickinson, Franklin Lakes, NJ) using keratinocyte
growth medium (Clonetics Corp., San Diego, CA). Cells were ¢xed in
3% paraformaldehyde in PBS, washed with PBS/0.1% BSA,
permeabilized with PBS containing 0.1% Triton-X 100 for 10 min, and
incubated with a mixture of serum sample from the respective patient and
the monoclonal anti-IQGAP1 antibody, diluted 1 : 40 in PBS/0.1% BSA,
washed, and subsequently incubated with the FITC-conjugated goat
F(ab0)2 anti-human IgG (Jaxell) and TRITC-conjugated goat anti-mouse
IgG (Jaxell). After ¢nal washing, cells and sections were embedded in
Fluoprep (BioMerieux, Marcy lEØ toile, France), coverslipped and
examined in a £uorescence microscope (Olympus BH-2, Melville, NY).
Immunoblotting and immunoprecipitation Biochemical procedures
were performed according to methods described previously (Foedinger et
al, 1995). Normal human keratinocytes obtained from surgically removed
skin grown to near con£uence were scraped and homogenized in 1%
nonidet P-40 (NP-40) (Calbiochem-Novabiochem, La Jolla, CA)/Tris-
bu¡ered saline, pH 7.4, with 2 mM phenylmethylsulfonyl £uoride (Sigma)
and a cocktail of proteinase inhibitors at a concentration of 5 mM
(leupeptin, antipain, chymostatin, pepstatin, all Calbiochem). Proteins
were precipitated by incubation with ethanol^acetone 1 : 1 solution
overnight at ^201C, and pellets resolubilized in 10% sodium dodecyl
sulfate (SDS) sample bu¡er. Extracted proteins were loaded on to 5%
SDS slab gels for polyacrylamide gel electrophoresis (PAGE). Separated
proteins were transferred to nitrocellulose membranes (Schleicher
& Schuell, Dassel, Germany). Strips of the blotted epidermal proteins
were blocked, incubated with patients’ sera or the respective controls,
washed, exposed to alkaline phosphatase-conjugated second step
antibody (Promega) followed by nitrobluetetrazolium/bromo-
chloroindolyl phosphatase (Kirkegaard & Perry Laboratories Inc.,
Gaithersburg, MA) to visualize bound antibodies. Alternatively, epidermal
sheets were used for protein extraction and processed the same way.
For immunoprecipitation, 1 ml aliquots of NP-40 lysates of cultured
keratinocytes or NP-40 Tris-bu¡ered saline were incubated with 10 mg
mouse monoclonal anti-IQGAP1 antibody (Transduction Laboratories),
for 1 h, at 41C. Antigen^antibody complexes were precipitated with
staphylococcal protein G-Sepharose (Sigma), boiled for 3 min in 10%
SDS sample bu¡er and separated by SDS^PAGE on 5% gels. Separated
proteins were transferred to nitrocellulose membranes (Schleicher &
Schuell), strips were cut out and further processed for immunoblotting
with patients’ sera and several controls. Alternatively, con£uent cultured
keratinocytes were incubated overnight with C-14-labeled amino acids
(New England Nuclear Boston, MA). NP-40 extracts of cells were
prepared, preabsorbed with normal human serum and then incubated
with sera of patients recognizing IQGAP1, normal human sera, mouse
monoclonal anti-IQGAP1, and polyclonal anti-IQGAP1 antibody. The
precipitated antigens were separated by SDS^PAGE on 5% gels and
transferred to nitrocellulose. Thereafter, the membrane was exposed to
mouse monoclonal anti-IQGAP1, and bound antibodies were visualized
by alkaline phosphatase-conjugated anti-mouse IgG and the respective
enzyme reaction. Additionally, the membrane was exposed for 6 wk to
visualize precipitated antigens by autoradiography.
Protein identi¢cation Lysates of cultured human keratinocytes were
loaded on to 5% SDS^PAGE slab gels and separated electrophoretically.
One-third of the gel was cut and proteins blotted to nitrocellulose. Strips
immunoblotted with serum of one patient were used to locate the protein
band of interest. The remaining parts of the gel were stained with
Coomassie Serva Blue G (Heidelberg, Germany). The corresponding
protein band was cut out of the gels and frozen in liquid nitrogen.
Tryptic digestion, mass spectrum analysis of the generated peptides, and
database analysis (SWISS-PROT database; Bairoch and Apweiler, 2000)
for protein identi¢cation was performed by Protana (Odense, Denmark).
BP180 enzyme-linked immunosorbent assay (ELISA) In order to
test sera of patients for the presence of autoantibodies directed against
BPAG 2 (180 kDa) we performed an ELISA using the BP180 ELISA kit
(MBL Medical & Biological Laboratories, Naka-ku Nagoya, Japan). The
ELISA is based on the recombinant BP180NC16a protein used as solid
phase antigen. We examined the sera of patients 1^5, sera of BP control
366 PRESSLAUER ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
patients as well as normal human sera according to the manufacturer’s
instructions (MBL). Brie£y, calibrator and patients’ sera are added to the
microwell coated with the BP180 antigen. After washing and application
of the peroxidase conjugate, the substrate incubation induces enzyme
reaction and color development. Adsorbance is photometrically evaluated
at 450 nm. The unit value (anti-BP180 value) is calculated as given in the
manufacturer’s manual and is seen positive when equal or larger than 9.
RESULTS
Demonstration of histology and in vivo bound
immunoreactants Histologic investigation of biopsy samples
of skin lesions (Fig 1a showing lesion of patient 4 diagnosed as
BP) revealed subepidermal blistering, spongiosis, and dermal in£a-
mmatory in¢ltrate with neutrophils and eosinophils (Fig 1b). In
addition, single keratinocytes of the basal cell layer even gave the
impression of focal detachment from neighboring cells (Fig 1b).
Direct immuno£uorescence of perilesional skin exhibited
discrete dots of bound IgG (Fig 1c) concentrated at adhesive
sites of neighboring keratinocytes. The labeling could be seen
along the cell periphery of individual keratinocytes throughout
the epidermis, whereas the most intense labeling was found at
the basal and suprabasal cell layers. Direct immuno£uorescence
from patient 5 showed additional linear IgG along the basement
membrane zone (not shown). C3 was found in a linear pattern
along the basement membrane zone in all biopsy specimens
(Fig 1d).
Circulating serum autoantibodies recognize a 190 kDa
antigen of keratinocytes Using immuno£uorescence and
immunoblotting to search for the presence of circulating
autoantibodies in ¢ve of 205 sera of patients with various
bullous skin eruptions we found a new, so far unknown
190 kDa antigen recognized by autoantibodies. When we
tested serum samples of the ¢ve patients by in-
direct immuno£uorescence on monkey esophagus we found
cytoplasmic staining of basal and suprabasal cells with bound
IgG predominantly at the cell periphery (Fig 2a). Serum of
patient 5 exhibited additional linear staining along the basement
membrane zone (Fig 2b); however, the latter reaction pattern
cannot necessarily claim speci¢city as 8% of our BP sera
(n¼ 90) gave a similar reaction. Split skin analysis revealed
linear staining of the blister roof only with serum of patient 5
(Fig 2d). Immunoblotting NP-40 lysates of cultured human
keratinocytes with sera of the ¢ve patients diagnosed as
erythema multiforme (patient 1) or erythema multiforme-like
eruption (patients 2 and 3) and BP (patients 4 and 5) showed
binding of autoantibodies to a polypeptide at 190 kDa (Fig 3,
lanes 5^9). Immunoblot of the serum from patient 5 showed an
additional band at 230 kDa (Fig 3, lane 5). Immunoblotting with
serum samples of further BP patients showed reactivity at 230
kDa (BPAG 1) and 180 kDa (BPAG 2) (Fig 3, lane 2). Periplakin,
the 195 kDa antigen recognized by paraneoplastic pemphigus
serum (Fig 3, lanes 3 and 4) was found clearly above the
respective 190 kDa polypeptide. The sera of the ¢ve patients
obviously recognized a new, so far unidenti¢ed antigen.
Figure1. A bullous lesion of patient 4 and its histologic and immu-
nomorphologic appearance. (a) The bulla on erythematous skin of pa-
tient 4 diagnosed as BP exhibits (b) subepidermal blistering, dermal
eosinophils, and, single keratinocytes detaching from the neighboring cells
in the basal cell layer. (c) Direct immuno£uorescence from the same lesion
reveals bound IgG in a dotted pattern along the cell periphery of individual
keratinocytes and (d) C3 along the basement membrane zone. Scale bars:
20 mm.
Figure 2. Indirect immuno£uorescence suggests the presence of cir-
culating autoantibodies against epidermal antigens. (a) Serum sample
from patient 1 gives cytoplasmic staining at the cell periphery of the basal
cells, whereas (b) serum from patient 5 reveals additional linear IgG along
the basement membrane zone of monkey esophagus. Indirect immuno-
£uorescence on normal human NaCl split skin performed with serum
samples from patients 1^4 reveals cytoplasmic staining within the epider-
mis and no labeling of the basement membrane zone (c, patient 4), whereas
(d) serum of patient 5 shows linear staining of the blister roof. Serum of a
BP patient gives linear staining along the blister roof in split skin analysis
(e). Scale bar: 40 mm.
Figure 3. Immunoblotting on epidermal extracts reveals reactivity
at 190 kDa. Lanes 5^9 show immunoblot from patients 1 to 5 exhibiting
the distinct band at 190 kDa, patient 5 (lane 5) additionally recognizing a
protein at 230 kDa appearing as BPAG 1. Lane 2 shows BPAG 1 (230 kDa)
and BPAG 2 (180 kDa). Lanes 3 and 4 give immunoblots of serum samples
from two patients with paraneoplastic pemphigus recognizing BPAG 1
(lane 3), Envoplakin (ENV, 210 kDa) and the 195 kDa periplakin (PPL).
Lane 10 gives the reaction with the monoclonal anti-IQGAP1 antibody at
190 kDa. Lane 1 shows the reactivity of desmoglein 1 (DG, 160 kDa).
AUTOANTIBODIES TO IQGAP1 367VOL. 120, NO. 3 MARCH 2003
Additional controls with sera of 10 healthy volunteers did not
stain any speci¢c band. When lysates of normal human
epidermis were immunoblotted with the same sera, we obtained
identical results (not shown).
Using a BP180 ELISA kit, we examined the sera of patients
1^5, seven BP sera and two normal human sera. Patient 5 in
the ELISA exhibited autoantibodies directed against BPAG 2
with an anti-BP180 value of 97. Sera of patients 1^4 and normal
human sera had unit values less than 9, which was according to
the manual the threshold value for positivity. The BP control sera
had unit values from 10 to 104.
Identi¢cation of IQGAP1, a human RasGAP-like protein
as antigenic target for autoantibodies To de¢ne the pro-
tein recognized by circulating autoantibodies NP-40 protein
lysates of cultured human keratinocytes were separated
electrophoretically. Gel slices containing the protein of interest
were localized, excised, and used for protein analysis. Protein
identi¢cation was based on tryptic digestion and mass spectrum
analysis of the generated peptides (performed by Protana,
Odense, Denmark). Amino acid sequence analysis of 40 peptide
fragments of various length revealed 100% homology to
IQGAP1 (Fig 4).
To certify further the identity of the antigen we performed
immunoprecipitation experiments with a boni¢ed mouse
monoclonal anti-IQGAP1 antibody. In a ¢rst step, we
immunoprecipitated IQGAP1 from NP-40 lysates of cultured
human keratinocytes. The precipitated proteins were separated
electrophoretically and transferred on to nitrocellulose. When
strips of nitrocellulose were immunoblotted with serum samples
from the ¢ve patients, the autoantibodies bound to a single
polypeptide at 190 kDa (Fig 5a, lanes 1^5). Immunoblotting of
the precipitated protein with the monoclonal anti-IQGAP1
antibody (Fig 5a, lane 7) and additionally, a polyclonal anti-
IQGAP1 antibody showed reactivity (Fig 5a, lane 6) with the
same protein, but serum samples of further BP patients (not
shown), several control sera of healthy volunteers (Fig 5a, lanes
9^10), and paraneoplastic pemphigus (Fig 5a, lane 8) did not bind
to precipitated IQGAP1. As additional control, this experiment
was performed using the monoclonal antibody and NP-40 lysis
bu¡er alone for precipitation, and subsequent immunoblotting
giving no speci¢c results (Fig 5a, lanes 11^15).
In a next step, immunoprecipitated proteins of C-14-labeled
human keratinocytes using patients’ sera, the monoclonal anti-
IQGAP1 antibody and controls were transferred on to a
nitrocellulose membrane. Thereafter, the whole membrane was
immunoblotted using mouse monoclonal anti-IQGAP1
antibody, giving a distinct reactivity at 190 kDa (Fig 5b).
Afterwards, the nitrocellulose membrane was exposed for
autoradiography. Sera of patients 1^4 precipitated only the
antigen at 190 kDa, serum of patient 5 also reacted with BPAG 1
(not shown).
Immuno£uorescence analysis of IQGAP1 antibodies on
normal human skin Using the serum autoantibodies and the
anti-IQGAP1 antibody for indirect immuno£uorescence
experiments on normal human skin, we obtained a combination
of a di¡use cytoplasmic pattern, more concentrated in the upper
epidermal layers, and a dotted staining at the periphery of
individual keratinocytes throughout all cell layers. We observed
this staining pattern with serum samples of patients 1^4 (Fig
6a). A similar pattern was found with the monoclonal anti-
IQGAP1 antibody (Fig 6c). Serum 5 showed additional weak
reactivity along the basement membrane zone of normal human
skin (Fig 6b).
IQGAP1 expression in cultured human keratino-
cytes Double labeling immuno£uorescence studies were
performed with serum samples and the monoclonal anti-
IQGAP1 antibody. Cultured human keratinocytes were grown
Figure 4. IQGAP1 is identi¢ed as target antigen for autoantibodies.
Peptide fragments matching homology with IQGAP1 (SWISS-PROT da-
tabase) are underlined and represented by the amino acids in bold letters.
Figure 5. Immunoprecipitation studies of IQGAP1 antibodies. (a)
When IQGAP1 was precipitated with monoclonal anti-IQGAP1 antibody
from lysates of cultured keratinocytes, transferred and immunoblotted
with the serum samples of patients 1 to 5 (lanes 1^5), with the rabbit anti-
IQGAP1 antibody (lane 6), and with the mouse monoclonal anti-IQGAP1
antibody (lane 7), speci¢c reactivity for IQGAP1was observed in all cases.
For control, immunoblotting with serum of paraneoplastic pemphigus pa-
tient was negative (lane 8). Lanes 9 and 10 show immunoblotting with nor-
mal human control sera, lanes 11^15 show immunoblotting with patients’
sera when immunoprecipitation was performed with murine anti-IQGAP1
antibody and lysis bu¡er alone. (b) For the reverse experiment, cultured
human keratinocytes were precipitated with the patients’ sera (lanes 3 and
5^8), the monoclonal anti-IQGAP1 antibody (lane 1), the polyclonal anti-
IQGAP1 antibody (lane 2), and a normal human control serum (lane 4).
After gel electrophoresis and transfer on to nitrocellulose, the membrane
was immunoblotted with the monoclonal anti-IQGAP1 antibody. A dis-
tinct single band could be observed at 190 kDa within all lanes except the
control serum.
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to con£uence and permeabilized with Triton-X 100. Immuno-
£uorescence with the monoclonal antibody demonstrates
IQGAP1 in cultured cells in a perinuclear localization, and, also,
at cell^cell adhesive sites in the periphery of the cells.We found
concordance of serum sample staining behavior and the
monoclonal anti-IQGAP1 antibody. Cells displayed a cyto-
plasmic staining pattern, and, in part, a distinct £uorescence
signal concentrated at adhesive sites of neighboring keratinocytes
(Fig 7a,b).
DISCUSSION
In this study, we show the expression of IQGAP1, a newly de-
scribed RasGAP-like protein (Weissbach et al, 1994) in human
keratinocytes, and, demonstrate the presence of circulating auto-
antibodies directed against IQGAP1 in patients with a bullous
skin disorder. Direct immuno£uorescence of perilesional skin
showed bound IgG in a dot-like pattern along the periphery of
individual keratinocytes indicative for IgG deposition at adhesive
sites of neighboring keratinocytes, and additionally C3 along the
basement membrane zone. Indirect immuno£uorescence on
monkey esophagus gave a cytoplasmic pattern along the periph-
ery of basal cells. These immunomorphologic ¢ndings suggested
the presence of circulating autoantibodies directed against epider-
mal antigens in our patients. Immunoblot analysis on lysates of
human keratinocytes revealed antibody binding to a 190 kDa
antigen in all ¢ve patients. Amino acid sequence analysis and
further immunoprecipitation studies using a boni¢ed monoclo-
nal antibody identi¢ed the protein as IQGAP1 (Weissbach et al,
1994), a protein suspected to act as an e¡ector molecule for Cdc
42 and Rac 1, members of the small GTPase family, and also
thought to play a part in E-cadherin-mediated cell adhesion
(Kuroda et al, 1998; Kaibuchi et al, 1999). The complex of antigens
characteristic for paraneoplastic pemphigus also includes a pro-
tein at approximately 190 kDa, periplakin.This is of further inter-
est as sera of some nonparaneoplastic pemphigus patients, e.g.,
BP, have been shown to react with periplakin (Nagata et al,
2001). Using a 5% SDS^PAGE for immunoblotting and immu-
noprecipitation as running condition, however, there is a striking
di¡erence between periplakin (Ma and Sun, 1986) of control
paraneoplastic pemphigus sera and IQGAP1. Additionally, two-
dimensional gel electrophoresis followed by immunoblotting
with sera of patients 1^4 and the monoclonal antibody showed
identical reactivity at about 190 kDa and pI between 6 and 7
(not shown). IQGAP1 is a large protein with IQ domains, se-
quence similarity to RasGAP-like proteins (Weissbach et al,
1994) and several protein binding motifs for direct binding to cal-
modulin (Ho et al, 1999; Li et al, 1999; Briggs et al, 2002), actin
(Erickson et al, 1997), the small GTPases Cdc42 and Rac1 (Kuroda
et al, 1996; Ho et al, 1999), E-cadherin (Kuroda et al, 1998), and b-
catenin (Kuroda et al, 1998; Briggs et al, 2002) thus providing evi-
dence for fundamental cellular metabolic and modulating e¡ects
as well as playing a key part in regulating E-cadherin-mediated
cell^cell adhesion and cytoskeletal organization (Kuroda et al,
1998; Kaibuchi et al, 1999). IQGAP1 has been reported to interact
with the N-terminal region of b-catenin, which contains the a-
catenin binding domain and to compete with a-catenin for bind-
ing to b-catenin and, if not bound to activated Cdc42 or Rac1,
IQGAP1 is able to dissociate a-catenin from the catenin^cadherin
complex negatively regulating E-cadherin-mediated cell^cell ad-
hesion (Kuroda et al, 1998; Kaibuchi et al, 1999). Depending on its
binding mode to linkage proteins, IQGAP1 can promote or inhi-
bit cadherin-based cell adhesion (Kaibuchi et al, 1999; Briggs et al,
2002). By double immuno£uorescence on cultured keratinocytes
with serum antibodies and the monoclonal anti-IQGAP1 anti-
body we found subcellular colocalization of the respective anti-
bodies. The expression of IQGAP1 in human keratinocytes
reported here was found at cell^cell adhesive sites in the periph-
ery of the cell close to the plasmalemma and in a perinuclear dis-
tribution within the cytoplasma, a pattern described for
IQGAP1 in various other cells (Kuroda et al, 1996, 1998; Erickson
et al, 1997; Li et al, 1999) where it is found associated with
Golgi membranes and the cytoskeleton near plasmalemma
anchored adhesion molecules (Kuroda et al, 1996; Ho et al, 1999).
According to these observations, in human keratinocytes
IQGAP1 may contribute to the organization and integrity of the
epidermal layer.
We here report of IQGAP1 in human keratinocytes, and of
autoantibodies directed to this antigen in association with a bul-
lous skin disorder. By immunoblotting and immunoprecipitation
lysates of keratinocytes with the 205 serum samples we did not
¢nd a 190 kDa antigen recognized by any sera of pemphigus vul-
garis or pemphigus foliaceus, but only by sera of our ¢ve pre-
sented patients diagnosed as erythema multiforme (or erythema
multiforme-like eruption) and BP. Clinically, the patients pre-
sented plaques, smaller and larger blisters, reminiscent of erythe-
ma multiforme and BP. Histology revealed subepidermal
blistering. Lesions showed linear C3 along the basement mem-
brane zone. Only one of the ¢ve patients described had addition-
ally autoantibodies against a 230 kDa protein, supposed to be
BPAG 1, and also showed linear IgG along the basement mem-
brane zone in direct and indirect immuno£uorescence. As de-
monstrated by BP180 ELISA, the serum from that patient
Figure 6. Indirect immuno£uorescence on normal human skin. (a)
Indirect immuno£uorescence of patient 1 shows a cytoplasmic staining pat-
tern of the epidermal keratinocytes. At the cell periphery focally dotted
staining can be observed throughout the epidermis. Similar reactivity is
seen with the serum of patient 5, whereas some reactivity is also seen along
the basement membrane zone (b). (c) For comparison, the monoclonal anti-
IQGAP1 antibody is used for immuno£uorescence on normal human skin.
There is a cytoplasmic staining and labeling of the cell periphery. Normal
human serum shows no speci¢c reactivity. Scale bar: 20 mm.
Figure 7. Double immuno£uorescence on cultured human kerati-
nocytes. (a) Serum of patient 1 and (b) the monoclonal anti-IQGAP1 anti-
body give staining within individual keratinocytes in a cytoplasmic pattern
and at the cell periphery at adhesive sites of neighboring keratinocytes.
Scale bar: 20 mm.
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reacted with BPAG 2, too. Determination of subclasses revealed
IgG1 (and IgG4) autoantibodies for potential complement bind-
ing activity (not shown). There are, however, some discrepancies
in clinical, biochemical, and immunomorphologic presentation
of the ¢ve patients, which show features of erythema multiforme
and BP. It is possible that further anti-BP 180 antibodies are be-
yond detection for biochemical methods, but could induce C3
deposition and induce pathogenic processes. These ¢ndings
strongly suggest that anti-IQGAP1 autoantibody-associated dis-
ease is related to or appears together with BP.
Autoantibodies in the pemphigus or pemphigoid disease are
directed in part against extracellular portions of the transmem-
branous target proteins that makes it easy to accept that an anti-
body^antigen reaction could initiate the pathogenic events (Hertl
et al, 1998; Hertl, 2000; Lin et al, 2000). The autoantibodies pre-
sented here are directed against an intracellularly located antigen,
a topographically much more controversial site to explain the
possible pathogenic relevance (Alarco¤ n-Segovia et al, 1996). Auto-
immune diseases, such as lupus erythematosus, however, which
can be viewed as a prototype for the breakdown of tolerance to
a wide spectrum of autoantigens are characterized by autoanti-
bodies directed against intracellular localized target molecules
(Alarco¤ n-Segovia et al, 1996; Sontheimer, 1999; Kamradt and
Mitchison, 2001). Studies with anti-nuclear antibodies of patients
with systemic lupus erythematosus indicate IgG antibody pene-
tration into living epithelial cells via receptor-mediated endocy-
tosis as a possible entrance mechanism (Golan et al, 1993). Reports
on pathogenic antibodies binding to glucose-6-phosphatase iso-
merase, a glycolytic enzyme localized intracellularly that induce
autoimmune arthritis (Matsumoto et al, 1999) indicate the exis-
tence of a di¡erent mechanism of autoimmunity. A recent report
on in vivo function of IQGAP1 showed that mice lacking
IQGAP1 develop gastric hyperplasia (Lin et al, 2000). Further stu-
dies showed that localization of IQGAP1 is inversely correlated
with E-cadherin mediated intercellular adhesion in gastric can-
cers (Takemoto et al, 2001), IQGAP1 overexpression in human
colorectal carcinomas (Nabeshima et al, 2002), and that IQGAP1
is upregulated in gastric cancer cells (Kamiyama and Inazawa,
2001) implying that IQGAP1 may play a part in cancer develop-
ment by modulating tumor cell adhesion (Briggs et al, 2002).
Considering these reports and the history of patients 1 (gastritis),
2 (colitis ulcerosa), and 4 (colon carcinoma 7 y before) the intri-
guing question arises whether the development of anti-IQGAP1
autoantibodies is of any importance in this context. It might be
possible that in the course of the gastroenteral disease exposure of
this intracellular antigen could lead to subsequent antibody de-
velopment. Considering the complex in vivo function of IQ-
GAP1, one could imagine that autoantibodies once inside the
cell might also interfere with binding motifs critically disturbing
cell adhesive mechanisms (Fukata et al, 2001). In that case, a local
in£ammatory reaction of the skin could support autoantibodies
directed against intracytoplasmic antigens to enter cells. There-
fore, it could be that IQGAP1 autoantibodies at the same time
represent an ‘‘epiphenomenon’’, which during the course of an-
other autoimmune bullous skin disease such as BP, circumstan-
tially gain functional relevance in perturbing a pathogenic
process. Addressing these questions will lead to further investiga-
tions involving experimental serum transfer studies and develop-
ment of an animal model of disease.
In summary, we demonstrate that IQGAP1, a newly described
multifunctional protein involved in cellular organization and cell
adhesion, is constitutively expressed by human keratinocytes.
Furthermore, we found autoantibodies in sera of patients with
distinct blistering skin eruptions potentially targeting that Ras
GTP-ase-like protein.
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